Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases.

Frontiers in endocrinology - 1 Jan 2024

Choi Ariel R, D'Agostino Ralph B, Farris Michael K, Abdulhaleem Mohammed, Hunting John C, Wang Yuezhu, Smith Margaret R, Ruiz Jimmy, Lycan Thomas W, Petty W Jeffrey, Cramer Christina K, Tatter Stephen B, Laxton Adrian W, White Jaclyn J, Li Wencheng, Su Jing, Whitlow Christopher, Xing Fei, Chan Michael D

Abstract excerpt

Purpose/objectives: Biomarkers for extracranial oligometastatic disease remain elusive and few studies have attempted to correlate genomic data to the presence of true oligometastatic disease. Methods: Patients with non-small cell lung cancer (NSCLC) and brain metastases were identified in our departmental database. Electronic medical records were used to identify patients for whom liquid biopsy-based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to Carcinoma, Non-Small-Cell Lung

Share to Disease Progression

Share to Genomics

Share to Lung Neoplasms

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 39355617
DOI: 10.3389/fendo.2024.1364021
PMCID: PMC11443040

Genes

ARID1A
ATM
CCNE1
JAK2
MAP2K2
NTRK1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases.PMID 39355617Read ↗

Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung Cancer.Semantic proximity Read ↗

Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases.Semantic proximity Read ↗

Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patients.Semantic proximity Read ↗

Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases.Semantic proximity Read ↗

Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases.Semantic proximity Read ↗

Genomic features and its potential implication in bone oligometastatic NSCLC.Semantic proximity Read ↗

Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival.Semantic proximity Read ↗

Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastasesSemantic proximity Read ↗

Genomic Analysis and Clinical Correlations of Non-Small Cell Lung Cancer (NSCLC) Brain Metastasis (BM)Semantic proximity Read ↗

Profiles of brain metastases: Prioritization of therapeutic targets.Semantic proximity Read ↗

Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.